AVR
NASDAQ · Health Care
Anteris Technologies Global
$5.32
-0.38 (-6.67%)
Financial Highlights (FY 2026)
Revenue
4.77M
Net Income
-235,020,948
Gross Margin
70.3%
Profit Margin
-4,921.3%
Rev Growth
-15.8%
D/E Ratio
—
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 4.77M | 5.67M | 55.67M | 50.34M |
| Gross Profit | 3.35M | 3.98M | 27.28M | 24.67M |
| Operating Income | -234,279,415 | -250,328,236 | 12.47M | 9.31M |
| Net Income | -235,020,948 | -251,120,566 | 8.34M | 8.70M |
| Gross Margin | 70.3% | 70.3% | 49.0% | 49.0% |
| Operating Margin | -4,908.2% | -4,417.4% | 22.4% | 18.5% |
| Profit Margin | -4,921.3% | -4,675.2% | 15.0% | 17.3% |
| Rev Growth | -15.8% | -15.8% | +16.7% | +18.7% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 0 | 0 | 58.12M | 59.46M |
| Total Equity | — | — | 133.98M | 123.04M |
| D/E Ratio | — | — | 0.43 | 0.48 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -230,256,947 | -259,698,563 | 15.39M | 14.55M |
| Free Cash Flow | — | — | 6.68M | 6.27M |